Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management

BACKGROUND: Patients with ulcerative colitis (UC) are at elevated risk of cardiovascular disease vs the general population, despite a lower prevalence of traditional risk factors, including hyperlipidemia. Mechanistic studies in patients with rheumatoid arthritis and psoriasis suggest that tofacitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sands, Bruce E, Colombel, Jean-Frédéric, Ha, Christina, Farnier, Michel, Armuzzi, Alessandro, Quirk, Daniel, Friedman, Gary S, Kwok, Kenneth, Salese, Leonardo, Su, Chinyu, Taub, Pam R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128390/
https://www.ncbi.nlm.nih.gov/pubmed/32870265
http://dx.doi.org/10.1093/ibd/izaa227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128390/
https://www.ncbi.nlm.nih.gov/pubmed/32870265
http://dx.doi.org/10.1093/ibd/izaa227

Ejemplares similares